Brief: Initial Ind Application For Asidna Granted “Study May Proceed” By The U.S. FDA

Valerio Therapeutics SA

30/06/2022 22:56

June 30 (Reuters) - Onxeo SA  ALONX.PA :
    * ONXEO: INITIAL IND APPLICATION FOR ASIDNA GRANTED “STUDY
MAY
PROCEED” BY THE U.S. FDA
    * ONXEO SA- TO INITIATE ITS FIRST PHASE 1B/2 TRIAL IN UNITED
STATES IN PATIENTS WITH SOLID TUMORS
    * ONXEO SA- PLANS TO INITIATE TRIAL IN SECOND HALF OF 2022
AT 3-5
POTENTIAL CLINICAL SITES ACROSS UNITED STATES

Source text for Eikon:  ID:nBw75lp2za 
Further company coverage:  ALONX.PA 

 ((Reuters.Briefs@thomsonreuters.com;))